fda drug shortages semaglutide injection shortage resolved 2025 ends as sets deadline for compounders FDA Removes Novo Nordisk's Ozempic®

Prior to that, in January 2023, we also made a commitment to broadening our focus to include end-to-end fill/finish capabilities by acquiring our Cincinnati facility from AstraZeneca, so this is something that weve been planning for some time

Update on the evaluation of thyroid nodules

Genetic Factors That May Influence Your GLP-1 Digestive Response Your genetic makeup influences how strongly your body responds to GLP-1 signaling and how severe gastrointestinal side effects may be

Up to this point, we may have been cautious about prescribing the oral preparation in this high-risk group

Insurance-dependent coverage also creates barriers

Obesity rates in 17 states and the Virgin Islands ranged from 30% to less than 35%